This drug candidate comes at an opportune time as Sörensen said in the release that there is a need for a new treatment for IPF. Currently, patients with this disease only have two FDA-approved ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Bloomberg High Yield Bond ETF (Symbol: JNK) where we have ...

Respiratory diseases rank among the foremost causes of mortality and disability globally, with long-term exposure to environmental pollutants playing a critical role in their onset and progression.

Credit lender International Personal Finance was established in 1997 as a division of Provident Financial. The unit was demerged in July 2007. It runs a lending business in eastern Europe and ...

The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended suspension of the idiopathic pulmonary fibrosis trial. Pliant Therapeutics will ...

The authors implement a valuable multi-tissue approach to dissect the physiologic consequences of JNK inhibition in parallel with dietary perturbation via sucrose. The conclusions of disrupted liver, ...

Traders and investors are closely monitoring the upcoming inflation data set to be released later this week, with both the Consumer Price Index and Producer Price Index in the spotlight. In light ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Bloomberg High Yield Bond ETF (Symbol: JNK) where we have ...

Because a number of cell-specific interactions have been described between TGF-β1-driven Smad signaling and the c-Jun N-terminal kinase (JNK) pathway, we have investigated the effects of JNK ...

Background: An association between idiopathic pulmonary fibrosis (IPF) and advancing age is suspected since IPF occurs primarily in patients over 60 years of age. Though, little is known about the ...

We report that disruption of the mixed-lineage protein kinase (MLK) - cJun NH 2-terminal kinase (JNK) signaling pathway in endothelial cells causes severe blockade of blood flow and failure to recover ...